Life Science AI Exchange Round Table: Practical Application

The August 2026 Life Science AI Exchange brought together industry experts from Merck Healthcare KGaA, Novo Nordisk and Sapio Sciences to explore the challenges of validation, trust and regulatory readiness for agentic AI in life sciences. The session examined why traditional approaches to computerised system validation may not translate directly to agentic AI, highlighting the importance of validating AI within its specific context of use, maintaining meaningful human oversight, ensuring data integrity and designing robust audit trails and governance controls. The roundtable also explored practical challenges including reviewer fatigue, explainability at scale and the need for shared verification standards, reinforcing the importance of continuous governance as AI becomes more deeply embedded in regulated workflows.

Learn more about the Life Science AI Exchange here.